1-Antitrypsin
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Recent studies have suggested that macrophage-derived metalloproteases are the critical mediators of cigarette smoke-induced emphysema, in contrast to earlier hypotheses that this process was mediated by
neutrophil elastase. To determine whether smoke can acutely induce connective tissue breakdown in the
lung and to examine the mediators of this process, we exposed C57-BL/6 mice to whole cigarette smoke
and used high-performance liquid chromatography to examine lavage fluid levels of desmosine (DES), a marker of elastin breakdown, and hydroxyproline (HP), a marker of collagen breakdown. Smoke produced a dose-response increase in lavage neutrophils, DES, and HP, but not lavage macrophages (MACs).
This effect was evident by 6 h after exposure to two cigarettes. Pretreatment with an antibody against
polymorphonuclear leukocytes (PMNs) reduced lavage PMNs to undetectable levels after smoke exposure, did not affect MAC numbers, and prevented increases in lavage DES and HP. Intraperitoneal injection of a commercial human
1-antitrypsin (
1AT) 24 h before smoke exposure increased serum
1AT
levels approximately 3-fold and completely abolished smoke-induced connective tissue breakdown as
well as the increase in lavage PMNs, again without affecting MAC numbers. We conclude that in this
model cigarette smoke can acutely induce connective tissue breakdown and that this effect is mediated by
neutrophil-derived serine proteases, most likely neutrophil elastase. Exogenous
1AT is protective and
appears to inhibit both matrix degradation and PMN influx, suggesting that
1AT has anti-inflammatory
as well as antiproteolytic effects in this system.
| |
Introduction |
|---|
|
|
|---|
Emphysema is characterized by abnormal irreversible enlargement of the air spaces in the lung resulting from progressive degradation of the extracellular matrix of the alveolar walls (1, 2). Evidence acquired over the past 30 years has led to the idea that matrix degradation results
from an excess of inflammatory cell-derived proteolytic
activity and a relative paucity of antiproteolytic defense in
the lower respiratory tract, a theory often referred to as
the protease-antiprotease hypothesis. In cigarette smokers, the traditional theory states that the effector cell is the
neutrophil (polymorphonuclear leukocyte [PMN]), the crucial protease neutrophil elastase, and that cigarette smoke
also inactivates
1-antitrypsin (
1AT), the major antiproteolytic substance in the lung parenchyma.
In patients with hereditary
1AT deficiency, this fundamental scenario appears to be correct, and some reports
suggest that progression of emphysema may be ameliorated by administration of
1AT (3, 4). However, in cigarette smokers the issue of what cell, what protease(s), and
what antiproteolytic substances are involved has become
increasingly controversial. Attempts to show that
1AT
levels in smokers are different from those in nonsmokers, or that the
1AT present has reduced function, have led to
contradictory results: some studies show lower levels of
1AT, or a decreased association rate between
1AT and
neutrophil elastase, or the presence of oxidized methionine residues in the protein leading to a loss of inhibitory
function; whereas an equal number of studies have shown
that
1AT levels in smokers are the same as those in nonsmokers and that there is no evidence of oxidative inactivation or other loss of function (reviewed in 2, 5).
The idea that the PMN is the effector cell has become equally controversial. Cigarette smoke causes an increase in both lavage and tissue PMNs and macrophages (MACs) (8). Although increased numbers of PMNs can be detected in the alveolar walls in smokers, and experimental instillation of neutrophil elastase produces emphysema in laboratory animals (10), the numbers of PMNs present in human tissue do not correlate with the degree of lung destruction, whereas correlations are obtained with numbers of MACs (9, 12). The traditional view that MAC proteases show little elastolytic activity compared with neutrophil elastase has been modified by the recognition that a variety of MAC-derived metalloproteases, including gelatinase A and B, matrilysin, and MAC metalloelastase, all can degrade elastin (13). It has also become apparent from human and experimental studies that emphysema is characterized not only by breakdown of elastin but also by breakdown and resynthesis of collagen with scar formation (2, 5, 16, 17).
These observations have led to an alternate formulation of the protease-antiprotease hypothesis in which MACs are the crucial cells and MAC-derived proteases, particularly metalloproteases, are the effector agents (14, 18). Sansores and colleagues (19) found that air space and interstitial MACs from smoke-exposed guinea pigs showed increased elastolytic activity, and Finlay and associates (20) reported similar observations using cultured MACs derived from human lavage fluid. Selman and colleagues (21) showed upregulation of interstitial collagenase in smoke-exposed guinea pigs, and D'Armiento and coworkers (22) showed that transgenic mice overexpressing interstitial collagenase developed emphysema. Hautamaki and associates (18) created mice in which the gene for MAC metalloelastase had been knocked out and observed that these mice did not develop emphysema when exposed to cigarette smoke. Ohnishi and coworkers (23) found increased levels of various metalloproteases including matrix metalloproteinase (MMP)-1, MMP-2, MMP-8, and MMP-9 in human lungs with emphysema compared with lungs without. More recently, Ofulue and associates (24) reported that the development of emphysema in smoke-exposed guinea pigs correlated with MAC but not PMN numbers and MAC-derived proteolytic activity, and that depletion of MACs prevented smoke-induced emphysema whereas depletion of PMNs was not protective (25).
All of these studies continue to raise questions about the cells and proteases involved in smoke-induced connective tissue breakdown in the lung, the process that ultimately leads to emphysema, as well as the time course of these events. In this study we have used a very acute smoke-injury model to examine connective tissue breakdown and to determine which cells and proteases (or groups of proteases) are involved.
| |
Materials and Methods |
|---|
|
|
|---|
Smoke Exposure and Lavage Procedures
Each experimental group consisted of five C57-BL/6 mice. Mice were exposed to the whole smoke from two full Kentucky 2R1 cigarettes (obtained from the University of Kentucky) using a standard smoking apparatus (described by us elsewhere [26]). Control mice were sham-smoked. At various times following smoke exposure, mice were killed by halothane overdose, and the lungs were removed from the chest cavity. A 20-gauge catheter was inserted into the trachea and the lungs were lavaged six times with 1 ml of ice-cold saline for cell counts or with distilled water for connective tissue degradation analysis (water was used because concentration of salts during sample preparation for the high-performance liquid chromatography [HPLC] procedure interferes with the analysis of desmosine [DES] [27]).
For inflammatory cell measurements, the saline lavage was centrifuged at 200 × g at 4°C for 10 min. The supernatants were decanted and the cell pellets were resuspended in 200 µl of saline. Total cell counts were performed in a hemacytometer and differential cell counts were performed on a 10-µl drop of the cell suspension heat-fixed on a slide and stained with hematoxylin and eosin.
To examine the effects of a single smoke exposure over time, C57-BL/6 mice were exposed to smoke from two whole cigarettes; test and control groups were killed 6, 24, and 48 h after smoke exposure, and their lungs were lavaged. To examine the effects of cigarette smoke dose, groups of mice were exposed to one, two, or three whole cigarettes and killed 24 h later.
1AT Purification, Administration, and Serum Levels
Purified human
1AT (Prolastin) was purchased from
Bayer, Inc. (Etobicoke, ON, Canada) and the preparation
was further purified to remove contaminating proteins.
Prolastin was reconstituted in 20 mM sodium phosphate
buffer (pH 7.6) and filtered through an Ultra-Free 15 100K
centrifugal filter device (Millipore, Bedford, MA) to remove proteins of 100-kD size or greater. The concentrate was washed several times with buffer and the resulting filtrates were pooled. The pooled filtrate was run through a
Cibacron Blue column (Pharmacia, Oakville, ON, Canada)
at 4°C to selectively remove albumin, the major contaminating protein. Human
1AT was washed out of the column with sodium phosphate buffer (pH 7.6). Finally, the
solution was concentrated with an Amicon ultrafiltration cell using a 10K Diaflo membrane (Amicon, Beverly, OK).
Purity of the resulting product was checked on a 12.5% homogenous Phastgel (Pharmacia) with silver staining.
Initial experiments were performed to determine the
increase in serum
1AT after injection of various amounts
of purified product and to determine the time course of
the serum elevation (see RESULTS) after intraperitoneal injection. For this purpose blood was drawn from the tail
vein and analyzed by a competitive enzyme-linked immunosorbent assay (ELISA) using purified human
1AT as a
standard (Calbiochem, La Jolla, CA). The plates were coated with 100 ng/well
1AT and blocked with phosphate-buffered saline (PBS) containing 3% bovine serum
albumin at pH 7.4. A total of 50 µl of sample was added
into the wells, followed by 50 µl of antihuman
1AT antibody (Boehringer Mannheim, Laval, PQ, Canada) depleted against mouse serum. After the solution was mixed,
the plate was incubated for 1 h at room temperature. After
incubation the plate was washed five times with PBS. A total of 100 µl of secondary antibody (goat antirabbit immunoglobulin G-horseradish peroxidase [HRP] 1:10,000) was
measured into each well. After 1 h incubation at room
temperature, the plate was washed five times with PBS.
The color reaction was developed using TMB ELISA substrate (ICN Biochemicals). A total of 100 µl of substrate
was added into each well and incubated for 5 min. Color
development was stopped by the addition of 100 µl 2 M
HCl solution. Absorbance was measured at 450 nm.
After examination of the data, a dose of 20 mg of purified product in 1.0 ml of saline was selected and mice were injected 24 h before smoke exposure.
Western Blot Analysis of Bronchoalveolar
Lavage Fluid for
1AT
Unconcentrated bronchoalveolar lavage (BAL) fluid
(BALF) samples were separated on a 12% polyacrylamide
resolving gel with purified human
1AT (Sigma, Mississauga, ON, Canada) as a positive control. After electrophoresis, the protein bands were immobilized on a nitrocellulose membrane and the membrane was probed with antihuman
1AT primary antibody (Boehringer Mannheim) and goat antirabbit HRP-conjugated antibody (ICN
Biochemicals) and developed by enhanced chemiluminescence (Amersham, Oakville, ON, Canada).
Depletion of Neutrophils
Neutrophils were depleted by administration of an antimouse neutrophil antibody (APA, Cat. no. AIA31140; Accurate Scientific, Westbury, NY). Two intraperitoneal injections of 0.2 ml of antibody were given 24 h apart. Test lavages and blood counts 24 h after intratracheal instillation of 50 µg of lipopolysaccharide (LPS) (used here as an agent known to evoke a marked lavage neutrophilia), administered 24 h after the second antibody dose, showed that this procedure succeeded in depleting 100% of the PMNs from the peripheral blood and more than 90% of the PMNs in the lavage. For smoke experiments, mice were exposed to smoke or air 24 h after the second antibody dose.
DES and Hydroxyproline Analysis
The water lavageate was lyophilized and hydrolyzed in HCl at 110°C for 48 h, and then analyzed for DES and hydroxyproline (HP) on a Waters HPLC system (Waters Associates, Milford, MA) using our previously published protocol (26).
BALF Elastase-Like Activity
Elastase-like activity in BALF was measured by colorimetric assay. BALF samples were lyophilized and reconstituted in water to make a solution that was five times more concentrated than the originial sample. N-succinyl-Ala-Ala-Ala-p-nitroanilide (SLAPN; Sigma) was used as the substrate. The assay was carried out in 0.2 M Tris-HCl, pH 8.0, with and without the addition of 10 mM ethylenediaminetetraacetic acid as a metalloelastase inhibitor or 10 mM N-methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone as a serine elastase inhibitor.
BAL samples were assayed in duplicate wells of 96-well flat bottom plates (VWR Canlab, Mississauga, ON, Canada). Each well contained 100 µl of the appropriate assay buffer as described earlier, 50 µl of 0.5 mg/ml SLAPN substrate, and 50 µl of sample. Negative control wells contained 150 µl of assay buffer and 50 µl of substrate. Background absorbance of each BAL sample was assessed by incubating 150 µl of assay buffer with 50 µl of BALF (this value was subtracted from the absorbance of the test wells). The absorbance of the wells was measured at 405 nm wavelength.
Statistics
Most comparisons were made by analysis of variance.
Because neutrophil counts were often zero (especially in
control animals and the neutrophil depletion or
1AT
treatment groups), comparisons were performed with the
nonparametric Kruskal-Wallis test, although the graphs
show means and standard deviations (SDs). Values of P < 0.05 or less were considered significant.
| |
Results |
|---|
|
|
|---|
Figure 1 shows the effects of cigarette dose with death at 24 h after smoke exposure. Lavage PMNs but not MACs increased with number of cigarettes smoked, but with a plateau after two cigarettes. Lavage DES and HP also increased with smoke dose in a similar fashion.
|
Figure 2 shows the effects over time of a single exposure to two cigarettes. PMNs were increased at 6 h, although the difference from control was not statistically significant, and were significantly elevated at 24 h. By 48 h neutrophil counts had decreased. MAC numbers were not affected by smoke. Both lavage DES and HP were increased at 6 and 24 h, but returned to baseline at 48 h.
|
Figure 3 shows the effects of anti-PMN antibody administered before smoke exposure as described in MATERIALS AND METHODS. The antibody reduced lavage PMN levels to zero and prevented smoke-mediated increases in DES and HP, again without affecting MAC numbers.
|
Figure 4 shows the effects of exogenous human
1AT
administered as described in MATERIALS AND METHODS on
serum
1AT levels and the time course of the serum elevation. Serum levels were increased two to three times
over normal C57-BL/6 levels (28) at 24 h and declined to
baseline over 7 d. Figure 5 illustrates Western blots of lavage fluid in animals given human
1AT; the human protein is present in the lavage fluid of both smoke- and air-exposed animals. Only a single band at 52 kD was observed and no complexes were identified. Figure 6 shows the effects of exogenous
1AT administration 24 h before
smoke exposure:
1AT totally abolished the smoke-mediated increases in PMNs, DES, and HP. MAC numbers
were not affected by exogenous
1AT.
|
|
|
Figure 7 shows lavage serine and metalloelastase-like
activity at 24 h after two cigarettes. Cigarette smoke exposure elevated both serine and metalloelastase activity, and
1AT returned the serine but not the metalloelastase levels to control values.
|
| |
Discussion |
|---|
|
|
|---|
In this paper we have examined the acute effects of cigarette smoke on connective tissue breakdown. The controversies regarding the effector cell(s) and protease(s) leading
to emphysema were considered in the opening paragraphs.
The quantification of connective tissue breakdown in smoke-
exposed humans has been similarly problematic and reports using various methods have given inconsistent results. Most investigators have examined urinary DES, and
early studies using radioimmunoassays concluded that
there was no detectable difference in urine DES levels between control and
1AT-deficient subjects (29) and no
correlation between urine DES and smoking status (30).
More recent studies suggest that plasma and BALF elastin-derived peptides are increased in smokers with evidence of chronic obstructive pulmonary disease (COPD)
(31, 32), and that the highest levels of urinary DES are
present in those individuals with the most rapid decline in
pulmonary function (33). Augmentation with
1AT reduces urinary DES levels in individuals with
1AT deficiency (34) and preliminary testing of a synthetic serine
elastase inhibitor also indicates it is capable of reducing urinary DES excretion in some patients with COPD (35).
Apart from problems of interfering substances, measurement of urinary or plasma DES is not entirely specific because it will pick up the normal elastin turnover from all organs in the body; Gottlieb and colleagues (33) noted that in normal individuals, only 19% of urinary DES is derived from the lung. Measurements of lavage DES are potentially more informative, but few data are available. Ofulue and associates (24) recently reported that, using a radioimmunoassay, elevated levels of both DES and elastin split products could be detected in the lavage fluid of rats 2 mo after initial smoke exposure, but not before. The present experiments extend this phenomenon more proximally: elevated levels of DES were evident within 6 h of smoke exposure, indicating that smoke can induce connective tissue breakdown as a very early event. The fact that HP levels were also elevated by 6 h serves to reinforce the idea that the proteolytic attack resulting from cigarette smoke exposure degrades a whole spectrum of matrix components, rather than just elastin.
Because smoke increases epithelial permeability it is remotely possible that smoke-induced leakage of normal serum DES and HP might spuriously increase lavage DES and HP. However, we were not able to detect any DES in normal mouse serum with our HPLC technique, with a detection limit determined from spiked samples of 3 pmol/ ml. By contrast, the lavage DES levels in our control animals were 20 to 30 pmol/ml and in the smoke-exposed animals on the order of 70 pmol/ml. Given that a normal mouse serum volume is about 1.5 ml, serum leakage could not account for more than a very small part of the increase in lavage connective tissue breakdown products.
The present experiments suggest that, in this very acute
model of smoke-induced injury, neutrophils act as the initial effector cells involved in connective tissue breakdown.
In our animals neutrophils constitute, on average, some 1 to
3% of lavage cells in the smoke-exposed mice, values comparable to those seen in human smokers (8). This increase
is more significant than might be thought from such small
numbers because in absolute terms, exposure to two cigarettes typically increases neutrophils manyfold (see figures).
The importance of increased neutrophil numbers is evident
from the experiments using antineutrophil antibody; by reducing neutrophil counts essentially to zero, connective tissue breakdown was abolished. Similarly, the efficacy of exogenous
1AT in preventing connective tissue breakdown
suggests that a serine protease is involved (but see later discussion), and the effect of
1AT in abolishing the elevated
serine elastase activity in the smokers is evident in Figure 7.
Although our experiments do not prove that that protease
is neutrophil elastase, this is the likely culprit because it is
the most potent elastase in the neutrophil armamentarium
and accounts for most neutrophil-derived elastolytic activity. However, other neutrophil proteases such as cathepsin
G and proteinase 3 may also play a role.
Our experiments raise the possibility that
1AT not
only may act to neutralize serine proteases, but also may
have an anti-inflammatory effect. DES and HP levels decreased in the animals given human
1AT in these experiments, but neutrophil levels returned to baseline as well,
suggesting that
1AT might be preventing connective tissue breakdown by decreasing neutrophil recruitment. Anti-inflammatory effects have been documented for several
different antiproteases. Both
1AT and
1-antichymotrypsin have been shown to decrease neutrophil chemotaxis in vitro (36, 37), at least partly by inhibiting the neutrophil-derived protease, cathepsin G, or by interacting
with a neutrophil surface-associated chymotrypsin-like enzyme, both of which appear to function in this context to
potentiate the chemotactic response (37). Secretory leukocyte protease inhibitor (SLPI) also decreases PMN influx
but by a different mechanism: Lentsch and coworkers (38)
have proposed that SLPI increases cytoplasmic I
B and
prevents activation of nuclear factor-
B, leading to decreased endothelial intercellular adhesion molecule-1 expression and decreased egress of PMNs from the circulation into the lung. We are currently investigating the actions
of
1AT in this regard.
However,
1AT can also act to upregulate the inflammatory response, inasmuch as complexes of
1AT and neutrophil elastase (39) or
1AT that has been proteolytically inactivated by macrophage elastase (40) act as neutrophil
chemoattractants. Moreover, both elastin- and collagen-
derived peptides are chemotactic for neutrophils (41, 42), so
it is also possible that by inhibiting neutrophil-mediated matrix proteolysis,
1AT prevents formation of chemotactic
peptide fragments and thus shuts off a positive feedback cycle. The current data on cigarette smoke exposure do not allow us to distinguish these possibilities. But it is interesting that when we administered
1AT along with LPS to mice,
we were able to return lavage DES completely to control
values even though lavage PMNs remained markedly elevated at 24 h (R. Dhami, unpublished data), suggesting that
direct
1AT-mediated protease neutralization can be important in preventing connective tissue breakdown.
Our data also raise some questions about the exact effects of small differences in
1AT levels. As noted at the
beginning of this paper, attempts to show directly that
functional levels of
1AT are reduced in smokers have
never yielded consistent results. C57-BL/6 mice have
1AT
levels that, in human terms, are within the normal range,
albeit slightly lower than other standard strains such as
NMRI or BALB/c mice (28). Nonetheless, this combination of smoke and endogenous
1AT leads to acute connective tissue breakdown, and the same level of smoke exposure also produces mild emphysema in C57- BL/6 mice if
administered daily over 6 mo ([18], and R. Dhami and associates, unpublished data). These findings indicate the
protease burden derived from acute cigarette smoke exposure is certainly able to overwhelm the protective effects of
endogenous
1AT in C57 mice. It is interesting in this regard that Sandford and colleagues (43) have recently reported the association of cigarette smoke-induced COPD
with the
1AT phenotype MZ, where the
1AT levels are
about 50% of those seen in MM subjects, but not in MS
subjects, where the level is about 75% of MM; and Campbell and coworkers (44) have shown that serum from MZ
and MS individuals provides slightly but significantly less
proteolytic protection than does serum from MM individuals in an in vitro assay system. The observations not only
emphasize the importance of
1AT (and by implication,
neutrophil elastase), but also suggest that even fairly small
variations in
1AT levels may lead to a situation in which
smoke-induced proteolysis overwhelms host defenses.
Our results clearly differ from several recent reports in
the literature that emphasize the role of MACs and metalloproteases in smoke-mediated proteolysis, as described in
this paper's opening paragraphs. The obvious and crucial
difference is that our experiments are very acute and provide no information about long-term changes. We cannot
rule out the possibility that MACs, or a combination of
neutrophils and MACs (and a combination of serine and
metalloproteases), play a greater role over time, as those
reports would imply. It is also possible that neutrophil-
mediated connective tissue breakdown is entirely a transient process but this seems unlikely since chronic smokers
have elevated lavage PMN levels (8); or that compensatory mechanisms serve to neutralize PMN-mediated proteolysis over time, which is one conclusion to be drawn
from the data of Ofulue and associates (24) who reported
that smoke-induced lavage and interstitial PMNs are increased at 1 mo and then decline in number, whereas
MAC increases and increases in lavage DES or elastin split products are not seen until 2 mo. Emphysema, which
in that study correlates with lavage DES levels, follows
MAC numbers and elastolytic activity. We did not attempt
to examine MAC function in the current study and it is
possible that MAC protease production is increased; the
metalloelastase activity we observed might be due to
MAC- or neutrophil-derived enzymes such as gelatinase
B (MMP-9). However, because adminstration of
1AT
decreases the serine but not the metalloelastase activity
and also returns lavage DES and HP to control levels,
metalloproteases do not appear to be playing any acute
role in connective tissue breakdown.
It is important to emphasize that the acute production
of neutrophil-mediated smoke-induced connective tissue
breakdown seen in our model does not necessarily translate into the development of emphysema over time. Unfortunately, the current experiments are necessarily very
short-term because repeated administration of anti-PMN
antibody or of human
1AT to these animals rapidly leads
to the development of serum sickness, making this approach unsuitable for longer studies. However, our data
do show that, acutely, smoke-evoked, neutrophil-derived
serine proteases can cause connective tissue breakdown in
the lung, and that
1AT is protective, perhaps through an
anti-inflammatory mechanism.
| |
Footnotes |
|---|
Address correspondence to: Andrew Churg, M.D., Dept. of Pathology, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, V6T 2B5 Canada. E-mail: achurg{at}interchange.ubc.ca
(Received in original form May 14, 1999 and in revised form August 19, 1999).
Abbreviations:
1-antitrypsin,
1AT; bronchoalveolar lavage, BAL; BAL
fluid, BALF; chronic obstructive pulmonary disease, COPD; desmosine,
DES; hydroxyproline, HP; high-performance liquid chromatography,
HPLC; macrophage, MAC; matrix metalloproteinase, MMP; polymorphonuclear leukocyte, PMN.
Acknowledgments: This work was supported by the Medical Research Council of Canada and the Bayer Blood Partnership Fund.
| |
References |
|---|
|
|
|---|
1. Snider, G. L., J. Kleinerman, W. Thurlbeck, and Z. Bengali. 1985. The definition of emphysema. Am. Rev. Respir. Dis. 132: 182-185 [Medline].
2. Senior, R. M., and N. R. Anthonisen. 1998. Chronic obstructive pulmonary disease (COPD). Am. J. Respir. Crit. Care Med. 157: S139-S147 .
3.
Pierce, J. A..
1997.
1-antitrypsin augmentation therapy.
Chest
112:
872-873
4.
The Alpha-1-Antitrypsin Deficiency Registry Study Group.
1998.
Survival
and FEV1 decline in individuals with severe deficiency of
1-antitrypsin.
Am. J. Respir. Crit. Care Med.
158:
49-59
5. Snider, G. L., E. Lucey, and P. J. Stone. 1994. Pitfalls in antiprotease therapy of emphysema. Am. J. Respir. Crit. Care Med. 150: S131-S137 .
6.
Evans, M. D., and
W. A. Pryor.
1994.
Cigarette smoking, emphysema, and
damage to
1-proteinase inhibitor.
Am. J. Physiol.
266:
L593-L611
7.
Ogushi, R.,
R. Hubbard,
C. Vogelmeier,
G. Fells, and
R. G. Crystal.
1991.
Risk factors for emphysema: cigarette smoking is associated with a reduction in the association rate constant of lung
1-antitrypsin for neutrophil
elastase.
J. Clin. Invest.
87:
1060-1065
.
8. Hunninghake, G., and R. G. Crystal. 1983. Cigarette smoking and lung destruction. Am. Rev. Respir. Dis. 128: 833-838 [Medline].
9. Finkelstein, R., R. Fraser, H. Ghezzo, and M. Cosio. 1995. Alveolar inflammation and its relation to emphysema in smokers. Am. J. Respir. Crit. Care Med. 152: 1666-1672 [Abstract].
10. Ludwig, P., B. Schwartz, J. Hoidal, and D. Niewoehner. 1985. Cigarette smoking causes accumulation of polymorphonuclear leukocytes in alveolar septum. Am. Rev. Respir. Dis. 131: 828-830 [Medline].
11. Janoff, A.. 1985. Elastases and emphysema: current assessment of the protease-antiprotease hypothesis. Am. Rev. Respir. Dis. 132: 417-433 [Medline].
12. Eidelman, D., M. Saetta, H. Ghezzo, N. Wang, J. Hoidal, M. King, and M. Cosio. 1990. Cellularity of the alveolar walls in smokers and its relation to alveolar destruction. Am. Rev. Respir. Dis 141: 1547-1552 [Medline].
13. Senior, R., N. Connolly, J. Cury, H. Welgus, and E. Campbell. 1989. Elastin degradation by human alveolar macrophages. Am. Rev. Respir. Dis. 139: 1251-1256 [Medline].
14. Shapiro, S. D.. 1994. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Am. J. Respir. Crit. Care Med. 150: S160-S164 .
15.
Senior, R. M.,
G. L. Griffin,
C. J. Fliszar,
S. D. Shapiro,
G. I. Goldberg, and
H. G. Welgus.
1991.
Human 92 and 72-kilodalton type IV collagenases are
elastases.
J. Biol. Chem.
266:
7870-7875
16. Cardoso, W. V., H. S. Sekhon, D. M. Hyde, and W. M. Thurlbeck. 1993. Collagen and elastin in human pulmonary emphysema. Am. Rev. Respir. Dis. 147: 975-981 [Medline].
17.
Wright, J. L., and
A. Churg.
1995.
Smoke-induced emphysema in the guinea
pig is associated with morphometric evidence of collagen breakdown and
repair.
Am. J. Physiol.
268:
L17-L20
18.
Hautamaki, R.,
D. Kobayashi,
R. Senior, and
S. Shapiro.
1997.
Requirement for macrophage elastase for cigarette smoke-induced emphysema in
mice.
Science
277:
2002-2004
19.
Sansore, R.,
R. Abboud,
C. Becceril,
M. Montano,
C. Ramos,
B. Vanda, and
M. Selman.
1997.
Effect of exposure of guinea pigs to cigarette smoke
on elastolytic activity of pulmonary macrophages.
Chest
112:
214-219
20.
Finlay, G. A.,
L. R. O'Driscoll,
K. J. Russel,
E. M. D'Arcy,
J. B. Masterson,
M. X. Fitzgerald, and
C. M. O'Connor.
1997.
Matrix metalloproteinase expression and production by alveolar macrophages in emphysema.
Am. J. Respir. Crit. Care Med.
156:
240-247
21. Selman, M., M. Montano, C. Ramos, B. Vanda, C. Becerril, F. Delgado, R. Sanores, R. Barrios, and A. Pardo. 1996. Tobacco smoke-induced lung emphysema in guinea pigs is associated with increased interstitial collagenase. Am. J. Physiol. L734-L739.
22. D'Armiento, J., S. Dalal, Y. Okada, R. Berg, and K. Chada. 1992. Collagenase expression in the lung of transgenic mice causes pulmonary emphysema. Cell 71: 955-961 [Medline].
23. Ohnishi, K., M. Takagi, Y. Kurokawa, S. Satomi, and Y. Konttinen. 1998. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab. Invest. 78: 1077-1086 [Medline].
24.
Ofulue, A.,
M. Ko, and
R. Abboud.
1998.
Time course of neutrophil and
macrophage elastinolytic activities in cigarette smoke-induced emphysema.
Am. J. Physiol.
275:
L1134-L1144
25.
Ofulue, A. F., and
M. Ko.
1999.
Effects of depletion of neutrophils or macrophages on development of cigarette smoke induced emphysema.
Am. J. Physiol.
277:
L97-L105
26.
Sekhon, H.,
J. L. Wright, and
A. Churg.
1994.
Cigarette smoke causes rapid
cell proliferation in small airways and associated pulmonary arteries.
Am.
J. Physiol.
267:
L557-L563
27.
Zay, K.,
S. Loo,
C. Xie,
D. V. Devine,
J. Wright, and
A. Churg.
1999.
The
role of neutrophils and
-1-antitrypsin in coal and silica-induced connective tissue breakdown.
Am. J. Physiol.
276:
L269-L279
28. Gardi, C., E. Cavarra, P. Calzoni, P. Maracolongo, M. de Santi, and P. Martorana. 1994. Neutrophil lysosomal dysfunctions in mutant C57-Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors. Biochem. J. 299: 237-245 .
29. Pelham, F., M. Wewers, R. G. Crystal, A. Buist, and A. Janoff. 1985. Urinary excretion of desmosine in subjects with PiZZ alpha-1-antitrypsin deficiency, a phenotype associated with hereditary predisposition to pulmonary emphysema. Am. Rev. Respir. Dis. 132: 821-823 [Medline].
30. Davies, S., K. Offord, M. Brown, H. Campe, and D. Niewoehner. 1983. Urine desmosine is unrelated to cigarette smoking or to spirometric function. Am. Rev. Respir. Dis. 128: 473-475 [Medline].
31. Schriver, E., J. Davidson, M. Sutcliffe, B. Swindell, and G. Bernard. 1992. Comparison of elastin peptide concentrations in body fluids from healthy volunteers, smokers, and patients with COPD. Am. Rev. Respir. Dis. 245: 762-766 .
32. Stone, P. J., D. Gottlieb, G. O'Connor, D. Ciccolella, R. Breuer, J. Bryan-Rhadfi, H. Shaw, C. Franzbalu, and G. L. Snider. 1995. Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 151: 952-959 [Abstract].
33. Gottleib, D., P. J. Stone, D. Sparrow, M. Gale, S. Weiss, G. Snider, and S. O'Connor. 1996. Urinary desmosine excretion in smokers with and without rapid decline of lung function. Am. J. Respir. Crit. Care Med. 154: 1290-1295 [Abstract].
34. Stone, P. J., T. Morris, C. Franzblau, and G. L. Snider. 1995. Preliminary evidence that augmentation therapy diminishes degradation of cross-linked elastin in alpha-1-antitrypsin deficient humans. Respiration 62: 76-79 [Medline].
35. Luisetti, M., C. Sturani, D. Sella, E. Madonini, V. Galavotti, G. Bruno, U. Kucich, G. Dagnino, J. Rosenbloom, B. Starcher, and C. Grassi. 1996. MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial. Eur. Respir. J. 9: 1482-1486 [Abstract].
36.
Stockley, R. A.,
J. Shaw,
S. C. Afford,
H. M. Morrison, and
D. Burnett.
1990.
Effect of
-1-proteinase inhibitor on neutrophil chemotaxis.
Am. J. Respir. Cell Mol. Biol.
2:
163-170
.
37.
Lomas, D. A.,
S. R. Stone,
C. Llewellyn-Jones,
M. T. Keogan,
Z. M. Wang,
H. Rubin,
R. W. Carrell, and
R. A. Stockley.
1995.
The control of neutrophil chemotaxis bv inhibitors of cathepsin G and chymotrypsin.
J. Biol.
Chem.
270:
23437-23443
38.
Lentsch, A. B.,
J. A. Jordan,
B. J. Czemak,
K. M. Diehl,
E. M. Younkin,
V. Sarma, and
P. Ward.
1999.
Inhibition of NF-
B activation and augmentation of I
B
by secretory leukocyte protease inhibitor during lung inflammation.
Am. J. Pathol.
154:
239-247
39.
Banda, M. J.,
A. G. Rice,
G. L. Griffin, and
R. M. Senior.
1988.
1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation
by macrophage elastase.
J. Biol. Chem.
263:
4481-4484
40.
Banda, M. J.,
A. G. Rice,
G. L. Griffin, and
R. M. Senior.
1988.
The inhibitory complex of human
1-proteinase inhibitor and human leukocyte
elastase is a neutrophil chemoattractant.
J. Exp. Med.
167:
1608-1615
41. Riley, D. J., R. A. Berg, R. A. Soltys, J. S. Kerr, H. N. Gusds, S. F. Curren, and D. L. Laskin. 1988. Neutrophil response following intratracheal instillation of collagen peptides into rat lungs. Exp. Lung Res. 14: 549-563 [Medline].
42. Senior, R. M., G. L. Griffin, and R. P. Mecham. 1980. Chemotactic activity of elastin-derived peptides. J. Clin. Invest. 66: 859-862 .
43.
Sandford, A. J.,
T. Weir,
J. J. Spinelli, and
P. D. Pare.
1999.
Z and S mutations of the
-1-antitrypsin gene and the risk of chronic obstructive pulmonary disease.
Am. J. Respir. Cell Mol. Biol.
20:
287-291
44. Campbell, E. J., M. A. Campbell, S. S. Boudkedes, and C. A. Owen. 1999. Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha(1)-antitrypsin deficiency. J. Clin. Invest. 104: 337-344 [Medline].
This article has been cited by other articles:
![]() |
M. Abolhassani, A. Guais, P. Chaumet-Riffaud, A. J. Sasco, and L. Schwartz Carbon dioxide inhalation causes pulmonary inflammation Am J Physiol Lung Cell Mol Physiol, April 1, 2009; 296(4): L657 - L665. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miller, J. Y. Cho, A. Pham, J. Ramsdell, and D. H. Broide Adiponectin and Functional Adiponectin Receptor 1 Are Expressed by Airway Epithelial Cells in Chronic Obstructive Pulmonary Disease J. Immunol., January 1, 2009; 182(1): 684 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Chung and I. M. Adcock Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Churg, M. Cosio, and J. L. Wright Mechanisms of cigarette smoke-induced COPD: insights from animal models Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L612 - L631. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Churg, R. Wang, X. Wang, P.-O. Onnervik, K. Thim, and J. L Wright Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs Thorax, August 1, 2007; 62(8): 706 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Nawrot, A. Nemmar, and B. Nemery Update in Environmental and Occupational Medicine 2006 Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 758 - 762. [Full Text] [PDF] |
||||
![]() |
S. M. Janciauskiene, I. M. Nita, and T. Stevens {alpha}1-Antitrypsin, Old Dog, New Tricks: {alpha}1-ANTITRYPSIN EXERTS IN VITRO ANTI-INFLAMMATORY ACTIVITY IN HUMAN MONOCYTES BY ELEVATING cAMP J. Biol. Chem., March 23, 2007; 282(12): 8573 - 8582. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schroeder, M. F. Vidal Melo, G. Musch, R. S. Harris, T. Winkler, and J. G. Venegas PET Imaging of Regional 18F-FDG Uptake and Lung Function After Cigarette Smoke Inhalation J. Nucl. Med., March 1, 2007; 48(3): 413 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Churg, H. Tai, T. Coulthard, R. Wang, and J. L. Wright Cigarette Smoke Drives Small Airway Remodeling by Induction of Growth Factors in the Airway Wall Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1327 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kriegova, C. Melle, V. Kolek, B. Hutyrova, F. Mrazek, A. Bleul, R. M. du Bois, F. von Eggeling, and M. Petrek Protein Profiles of Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1145 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
R O'Donnell, D Breen, S Wilson, and R Djukanovic Inflammatory cells in the airways in COPD Thorax, May 1, 2006; 61(5): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Senn, E. W. Russi, M. Imboden, and N. M. Probst-Hensch {alpha}1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants Eur. Respir. J., November 1, 2005; 26(5): 909 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Owen Proteinases and Oxidants as Targets in the Treatment of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 373 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Wu, Y. Shoji, M.-C. Wu, P.-C. Chuang, C.-C. Lin, M.-F. Huang, and S.-J. Tsai Suppression of Matrix Metalloproteinase-9 by Prostaglandin E2 in Peritoneal Macrophage Is Associated with Severity of Endometriosis Am. J. Pathol., October 1, 2005; 167(4): 1061 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Thatcher, N. A. McHugh, R. W. Egan, R. W. Chapman, J. A. Hey, C. K. Turner, M. R. Redonnet, K. E. Seweryniak, P. J. Sime, and R. P. Phipps Role of CXCR2 in cigarette smoke-induced lung inflammation Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L322 - L328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Birrell, S. Wong, D. J. Hele, K. McCluskie, E. Hardaker, and M. G. Belvisi Steroid-resistant Inflammation in a Rat Model of Chronic Obstructive Pulmonary Disease Is Associated with a Lack of Nuclear Factor-{kappa}B Pathway Activation Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 74 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ito, E. P. Ingenito, K. K. Brewer, L. D. Black, H. Parameswaran, K. R. Lutchen, and B. Suki Mechanics, nonlinearity, and failure strength of lung tissue in a mouse model of emphysema: possible role of collagen remodeling J Appl Physiol, February 1, 2005; 98(2): 503 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Churg, R. D. Wang, H. Tai, X. Wang, C. Xie, and J. L. Wright Tumor Necrosis Factor-{alpha} Drives 70% of Cigarette Smoke-induced Emphysema in the Mouse Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 492 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
H van der Vaart, D S Postma, W Timens, and N H T Ten Hacken Acute effects of cigarette smoke on inflammation and oxidative stress: a review Thorax, August 1, 2004; 59(8): 713 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Valenca, K. Da Hora, P. Castro, V. G. Moraes, L. Carvalho, and L. Cristo Vao De Moraes Sobrino Porto Emphysema and Metalloelastase Expression in Mouse Lung Induced by Cigarette Smoke Toxicol Pathol, April 1, 2004; 32(3): 351 - 356. [Abstract] [PDF] |
||||
![]() |
E{-}J.D. Oudijk, J{-}W.J. Lammers, and L. Koenderman Systemic inflammation in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 5s - 13s. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Numanami, S. Koyama, D. K. Nelson, J. C. Hoyt, J. L. Freels, M. P. Habib, J. Amano, M. Haniuda, E. Sato, and R. A. Robbins Serine Protease Inhibitors Modulate Smoke-Induced Chemokine Release From Human Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., November 1, 2003; 29(5): 613 - 619. [Abstract] [Full Text] |
||||
![]() |
R. A. Stockley "Knock-out" Mouse: Down But Not Out Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 145 - 146. [Full Text] [PDF] |
||||
![]() |
A. Churg, R. D. Wang, C. Xie, and J. L. Wright {alpha}-1-Antitrypsin Ameliorates Cigarette Smoke-induced Emphysema in the Mouse Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 199 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Foronjy, Y. Okada, R. Cole, and J. D'Armiento Progressive adult-onset emphysema in transgenic mice expressing human MMP-1 in the lung Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L727 - L737. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Snider Understanding Inflammation in Chronic Obstructive Pulmonary Disease: The Process Begins Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1045 - 1046. [Full Text] [PDF] |
||||
![]() |
A. Churg, R. D. Wang, H. Tai, X. Wang, C. Xie, J. Dai, S. D. Shapiro, and J. L. Wright Macrophage Metalloelastase Mediates Acute Cigarette Smoke-induced Inflammation via Tumor Necrosis Factor-{alpha} Release Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1083 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Elliot, N. G. Carroll, A. L. James, and P. J. Robinson Airway Alveolar Attachment Points and Exposure to Cigarette Smoke In Utero Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 45 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wright, S. G. Farmer, and A. Churg Synthetic Serine Elastase Inhibitor Reduces Cigarette Smoke-induced Emphysema in Guinea Pigs Am. J. Respir. Crit. Care Med., October 1, 2002; 166(7): 954 - 960. [Abstract] [Full Text] |
||||
![]() |
R Mahadeva and S D Shapiro Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema Thorax, October 1, 2002; 57(10): 908 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Churg, J. Dai, H. Tai, C. Xie, and J. L. Wright Tumor Necrosis Factor-{alpha} Is Central to Acute Cigarette Smoke-induced Inflammation and Connective Tissue Breakdown Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 849 - 854. [Abstract] [Full Text] |
||||
![]() |
A. Churg, K. Zay, S. Shay, C. Xie, S. D. Shapiro, R. Hendricks, and J. L Wright Acute Cigarette Smoke-Induced Connective Tissue Breakdown Requires both Neutrophils and Macrophage Metalloelastase in Mice Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 368 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
J C Hogg and R M Senior Chronic obstructive pulmonary disease c 2: Pathology and biochemistry of emphysema Thorax, September 1, 2002; 57(9): 830 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuraki, M. Ishibashi, M. Takayama, M. Shiraishi, and M. Yoshida A Novel Oral Neutrophil Elastase Inhibitor (ONO-6818) Inhibits Human Neutrophil Elastase-induced Emphysema in Rats Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 496 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A Dawkins and R A Stockley Animal models of chronic obstructive pulmonary disease Thorax, December 1, 2001; 56(12): 972 - 977. [Full Text] [PDF] |
||||
![]() |
E. CAVARRA, B. BARTALESI, M. LUCATTELLI, S. FINESCHI, B. LUNGHI, F. GAMBELLI, L. A. ORTIZ, P. A. MARTORANA, and G. LUNGARELLA Effects of Cigarette Smoke in Mice with Different Levels of alpha 1-Proteinase Inhibitor and Sensitivity to Oxidants Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 886 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
R A Stockley Alpha-1-antitrypsin deficiency: what next? Thorax, July 1, 2000; 55(7): 614 - 618. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |